Home » EMEA Grants Orphan Drug Status to Active Biotech’s Cancer Treatment Anyara
EMEA Grants Orphan Drug Status to Active Biotech’s Cancer Treatment Anyara
Active Biotech AB announced that Anyara has been granted Orphan Drug Status by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA).
Ad-Hoc-News
Upcoming Events
-
07May
-
14May
-
30May